Science Stock Financials

SSAA
 Stock
  

USD 9.87  0.03  0.30%   

You can exercise Science Strategic fundamental data analysis to find out if markets are presently mispricing the firm. We were able to analyze seventeen available drivers for Science Strategic Acquisition, which can be compared to its competition. Use Science Strategic cash and equivalents, as well as the relationship between the book value per share and earnings per share to make sure your decision on pricing Science Strategic is adequate. Given that Science Strategic has a cash and equivalents of 346.32 K, we advise you to double-check Science Strategic Acquisition current market performance to make sure the company can sustain itself down the road. Use Science Strategic to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a normal downward trend and little activity. Check odds of Science Strategic to be traded at $9.77 in 90 days.
  
With this module, you can analyze Science financials for your investing period. You should be able to track the changes in Science Strategic individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Science Most Recent Estimates

Quarterly Earnings Growth YOY
1.23
Diluted Eps
0.07
Earnings Share
0.07
Understanding current and past Science Strategic Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Science Strategic's financial statements are interrelated, with each one affecting the others. For example, an increase in Science Strategic's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 69
Science Strategic Acquisition has more than 69 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Science Strategic stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Science Strategic's official financial statements usually reflect Science Strategic's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Science Strategic. For example, before you start analyzing numbers published by Science accountants, it's critical to develop an understanding of what Science Strategic's liquidity, profitability, and earnings quality are in the context of the Financial Services space in which it operates.
Please note, the presentation of Science Strategic's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Science Strategic's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Science Strategic's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Science Strategic Acquisition. Please utilize our Beneish M Score to check the likelihood of Science Strategic's management to manipulate its earnings.

Science Strategic Company Summary

Science Strategic competes with Alphabet. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in the direct-to-consumer brands, D2C services, and mobile and social entertainment sectors. The company was incorporated in 2020 and is based in Santa Monica, California. Science Strategic is traded on NASDAQ Exchange in the United States.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address1447 2nd Street
SectorFinancial Services
IndustryShell Companies
BenchmarkDOW
Websitewww.science-inc.com/ssaa
Phone310 393 3024
CurrencyUSD - US Dollar

Science Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Science Strategic's current stock value. Our valuation model uses many indicators to compare Science Strategic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science Strategic competition to find correlations between indicators driving Science Strategic's intrinsic value. More Info.
Science Strategic Acquisition is currently regarded number one company in current valuation category among related companies. It is currently regarded as top stock in shares owned by institutions category among related companies . The ratio of Current Valuation to Shares Owned by Institutions for Science Strategic Acquisition is about  4,462,150 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Science Strategic by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Science Strategic's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Science Strategic's earnings, one of the primary drivers of an investment's value.

Science Strategic Systematic Risk

Science Strategic's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Science Strategic volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-one with a total number of output elements of thirty. The Beta measures systematic risk based on how returns on Science Strategic correlated with the market. If Beta is less than 0 Science Strategic generally moves in the opposite direction as compared to the market. If Science Strategic Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Science Strategic is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Science Strategic is generally in the same direction as the market. If Beta > 1 Science Strategic moves generally in the same direction as, but more than the movement of the benchmark.
.

About Science Strategic Financials

What exactly are Science Strategic Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Science Strategic's income statement, its balance sheet, and the statement of cash flows. Potential Science Strategic investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Science Strategic investors may use each financial statement separately, they are all related. The changes in Science Strategic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Science Strategic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Science Strategic is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Science grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Science Strategic August 14, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Science Strategic help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Science Strategic Acquisition. We use our internally-developed statistical techniques to arrive at the intrinsic value of Science Strategic Acquisition based on widely used predictive technical indicators. In general, we focus on analyzing Science Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Science Strategic's daily price indicators and compare them against related drivers.
Downside Deviation0.3122
Information Ratio(0.41)
Maximum Drawdown1.12
Value At Risk(0.30)
Potential Upside0.3052
Additionally, take a look at World Market Map. Note that the Science Strategic information on this page should be used as a complementary analysis to other Science Strategic's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Science Stock analysis

When running Science Strategic price analysis, check to measure Science Strategic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Strategic is operating at the current time. Most of Science Strategic's value examination focuses on studying past and present price action to predict the probability of Science Strategic's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Science Strategic's price. Additionally, you may evaluate how the addition of Science Strategic to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Is Science Strategic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Strategic. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Strategic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.23
Market Capitalization
381.9 M
Return On Assets
-0.0118
The market value of Science Strategic is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Strategic's value that differs from its market value or its book value, called intrinsic value, which is Science Strategic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Strategic's market value can be influenced by many factors that don't directly affect Science Strategic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Strategic's value and its price as these two are different measures arrived at by different means. Investors typically determine Science Strategic value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Strategic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.